Venatorx
venatorx.com
As featured in
Claim pageClaim
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$42M
14 rounds on record
Latest round
$42M
Venture round · Jul 2017 · 9 yr ago
Grants
$26.5M
13 grants · CORDIS
Backers
1
Foresite Capital
The money's age
Long since its last round
111 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Apr 1, 2024
Won a grant $2M · CORDIS
Jul 24, 2023
Won a grant $600k · CORDIS
Jun 7, 2023
Won a grant $3M · CORDIS
Mar 10, 2022
Won a grant $3M · CORDIS
May 24, 2021
Won a grant $3M · CORDIS
Dec 15, 2020
Won a grant $507k · CORDIS
Jul 15, 2020
Won a grant $600k · CORDIS
May 15, 2019
Won a grant $3M · CORDIS
Feb 7, 2018
Won a grant $3M · CORDIS
Aug 7, 2017
Won a grant $3M · CORDIS
Jul 25, 2017
Raised a round Venture round $42M
Mar 15, 2017
Won a grant $600k · CORDIS
Jul 5, 2016
Won a grant $3.5M · CORDIS
Jul 2, 2016
Won a grant $691k · CORDIS
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Grant | Apr 2024 | $2M | — | CORDIS |
| Grant | Jul 2023 | $600k | — | CORDIS |
| Grant | Jun 2023 | $3M | — | CORDIS |
| Grant | Mar 2022 | $3M | — | CORDIS |
| Grant | May 2021 | $3M | — | CORDIS |
| Grant | Dec 2020 | $507k | — | CORDIS |
| Grant | Jul 2020 | $600k | — | CORDIS |
| Grant | May 2019 | $3M | — | CORDIS |
| Grant | Feb 2018 | $3M | — | CORDIS |
| Grant | Aug 2017 | $3M | — | CORDIS |
| Venture round | Jul 2017 | $42M | — | fiercebiotech.com |
| Grant | Mar 2017 | $600k | — | CORDIS |
| Grant | Jul 2016 | $3.5M | — | CORDIS |
| Grant | Jul 2016 | $691k | — | CORDIS |
Backed byfrom the funds' portfolios and accelerator catalogs
Foresite Capital News
Basilea secures rights to Venatorx's antibiotic for complicated UTIs
Basilea expects to begin a Phase III trial with the antibiotic candidate in around 18 months.
Read more
Report
Venatorx, Melinta's BARDA-funded antibiotic combo falls short with manufacturing-related rejection
Read more
Report
Venatorx Pharmaceuticals and Menarini Group Enter Commercial Agreement for Cefepime-Taniborbactam in 96 Countries
/PRNewswire/ -- Venatorx Pharmaceuticals, a private, pre-commercial pharmaceutical company focused on improving health outcomes for patients with...
Read more
Report
Venatorx lands third BARDA contract for development of new antibiotics, this one worth up to $167M
Read more
Report
Venatorx awarded BARDA contract to develop oral ceftibuten-ledaborbactam etzadroxil to treat complicated urinary tract infection
Venatorx awarded BARDA contract to develop oral ceftibuten-ledaborbactam etzadroxil to treat complicated urinary tract infection
Read more
Report
Everest Medicines Announces that Licensing Partner Venatorx Pharmaceuticals Reports Positive Results from Pivotal Phase 3 Cefepime-Taniborbactam Trial
/PRNewswire/ -- Everest Medicines (HKEX 1952.HK) announced today that its licensing partner, Venatorx Pharmaceuticals, reported positive results from its...
Read more
Report
VC-backed VenatoRx beefs up team with three new hires
Malvern, Pennsylvania-based VenatoRx, a pharmaceutical company focused on developing novel anti-infectives to treat multi-drug-resistant bacterial infections and hard-to-treat viral infections, has expanded its team with three new additions. Jennifer Elli
Read more
Report
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Malvern
United States
HQ
Financials
Total raised
$68.5M
Latest round
Grant
Funding rounds
14
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Grant | 2024 | $2M | Details |
| Grant | 2023 | $600k | Details |
| Grant | 2023 | $3M | Details |
| Grant | 2022 | $3M | Details |
| Grant | 2021 | $3M | Details |
| Grant | 2020 | $507k | Details |
| Grant | 2020 | $600k | Details |
| Grant | 2019 | $3M | Details |
| Grant | 2018 | $3M | Details |
| Grant | 2017 | $3M | Details |
| Venture - Series Unknown | 2017 | $42M | Details |
| Grant | 2017 | $600k | Details |
| Grant | 2016 | $3.5M | Details |
| Grant | 2016 | $691k | Details |